Similarly, patients with a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2 should avoid semaglutide
While GLP-1 clearly affects appetite centers in the brain, adding GIP agonism might influence different neural circuits related to food reward, energy expenditure, or metabolic regulation
Its first registrational Phase 3 obesity trial has confirmed weight loss outcomes that approach those previously achievable only through bariatric surgery, with meaningful cardiometabolic improvements alongside
Genetic variants including GIPR rs1800437 , GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 relate to the biological pathways these medications act on
It influences where you store fat (shifting from hips/thighs to abdomen), how sensitive your cells are to insulin, and how well you build and maintain muscle
GLP-1 plays a pivotal role in regulating blood sugar levels and appetite, making it an effective tool for sustainable weight management